Retour
Fourchette du Jour
25,29 €
26,12 €
Fourchette 52 Semaines
14,59 €
44,28 €
Volume
202 945
Moyenne 50J / 200J
33,34 €
/
27,63 €
Clôture Précédente
25,00 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -31,7 | 0,4 |
| P/B | 1,6 | 2,9 |
| ROE % | -5,2 | 3,8 |
| Net Margin % | -7,0 | 3,9 |
| Rev Growth 5Y % | 38,3 | 10,0 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Hold
49,80 €
+93.4%
Low: 47,00 €
High: 52,00 €
BPA Prévisionnel
-1,18 €
CA Est.
350 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
1,02 €
1,01 € – 1,03 €
|
510 M | 1 |
| FY2029 |
0,57 €
0,56 € – 0,57 €
|
470 M | 1 |
| FY2028 |
-0,03 €
-0,36 € – 0,31 €
|
430 M | 5 |
Insider Trading Activity
Buy ratio (90d)
0.0%
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 5, 2026 |
Stokes Frank
Chief Financial Officer
|
sell | 6 001 | 27,98 € | 167 908 € |
| Jan 12, 2026 |
Stokes Frank
Chief Financial Officer
|
grant | 16 248 | — | — |
| Dec 17, 2025 |
Oelschlager Kristen M
Chief Operating Officer
|
sell | 14 888 | 39,31 € | 585 292 € |
| Dec 11, 2025 |
Stokes Frank
Chief Financial Officer
|
sell | 4 496 | 37,45 € | 168 375 € |
| Dec 10, 2025 |
Stokes Frank
Chief Financial Officer
|
other | 15 098 | — | — |
| Dec 10, 2025 |
Oelschlager Kristen M
Chief Operating Officer
|
other | 14 892 | — | — |
| Dec 9, 2025 |
Stokes Frank
Chief Financial Officer
|
other | 35 766 | — | — |
| Dec 9, 2025 |
Oelschlager Kristen M
Chief Operating Officer
|
other | 36 613 | — | — |
| Nov 11, 2025 |
Oelschlager Kristen M
Chief Operating Officer
|
sell | 18 932 | 35,10 € | 664 513 € |
| Nov 11, 2025 |
Stokes Frank
Chief Financial Officer
|
sell | 5 388 | 35,08 € | 189 011 € |
| Oct 31, 2025 |
Oelschlager Kristen M
Chief Operating Officer
|
sell | 12 678 | 25,04 € | 317 457 € |
| Aug 8, 2025 |
Juvenal Tobin W
Chief Commercial Officer
|
other | 25 574 | — | — |
| May 22, 2025 |
Harrison Miles
Director
|
grant | 13 667 | — | — |
| May 22, 2025 |
Cole G Bradley
Director
|
grant | 13 667 | — | — |
| May 22, 2025 |
Caple Kim
Director
|
grant | 13 667 | — | — |
| May 22, 2025 |
Cotton Rodney
Director
|
grant | 13 667 | — | — |
| May 21, 2025 |
Harrison Miles
Director
|
other | 17 346 | — | — |
| May 21, 2025 |
Cole G Bradley
Director
|
other | 17 346 | — | — |
| May 21, 2025 |
Caple Kim
Director
|
other | 17 346 | — | — |
| May 21, 2025 |
Cotton Rodney
Director
|
other | 17 346 | — | — |
Points Clés
Revenue grew 38,30% annually over 5 years — strong growth
Earnings declined -232,41% over the past year
Debt/Equity of 0,08 — conservative balance sheet
Generating 28,33M in free cash flow
PEG of 0,21 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 34,64%
Croissance
Revenue Growth (5Y)
38,30%
Revenue (1Y)3,66%
Earnings (1Y)-232,41%
FCF Growth (3Y)N/A
Qualité
Return on Equity
-5,21%
ROIC-6,32%
Net Margin-7,02%
Op. Margin-12,44%
Sécurité
Debt / Equity
0,08
Current Ratio5,26
Interest Coverage-497,79
Valorisation
P/E Ratio
-31,69
P/B Ratio1,63
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3,66% | Revenue Growth (3Y) | 25,15% |
| Earnings Growth (1Y) | -232,41% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 38,30% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 344,23M | Net Income (TTM) | -24,16M |
| ROE | -5,21% | ROA | -4,18% |
| Gross Margin | 68,66% | Operating Margin | -12,44% |
| Net Margin | -7,02% | Free Cash Flow (TTM) | 28,33M |
| ROIC | -6,32% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,08 | Current Ratio | 5,26 |
| Interest Coverage | -497,79 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -31,69 | P/B Ratio | 1,63 |
| P/S Ratio | 2,22 | PEG Ratio | 0,21 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 765,58M | Enterprise Value | 685,76M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 344,23M | 332,07M | 219,79M | 137,04M | 94,09M |
| Net Income | -24,16M | 18,25M | -57,47M | -67,14M | -31,29M |
| EPS (Diluted) | -0,83 | 0,62 | -2,14 | -2,58 | -1,24 |
| Gross Profit | 236,35M | 271,86M | 174,81M | 105,03M | 78,26M |
| Operating Income | -42,81M | 8,67M | -67,98M | -72,86M | -40,08M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 578,56M | 531,24M | 453,34M | 447,33M | 462,57M |
| Total Liabilities | 107,68M | 75,40M | 62,07M | 48,18M | 50,83M |
| Shareholders' Equity | 470,87M | 455,84M | 391,27M | 399,15M | 411,74M |
| Total Debt | 36,91M | 26,34M | 15,34M | 13,40M | 8,20M |
| Cash & Equivalents | 116,73M | 119,71M | 98,84M | 122,95M | 329,63M |
| Current Assets | 361,10M | 360,15M | 295,64M | 292,29M | 353,74M |
| Current Liabilities | 68,68M | 49,39M | 47,67M | 36,13M | 24,89M |